Washington, Sept. 26 -- US President Donald Trump on Thursday unveiled fresh tariffs of up to 100 percent on imports of branded and patented pharmaceutical products, effective October 1, 2025 - a move that could deal a heavy blow to India's pharma industry, one of the country's most trade-reliant sectors with America.

The announcement underlined Trump's continued push for tariffs beyond the sweeping duties introduced in August, signalling his confidence that import taxes can shrink the US fiscal deficit while bolstering domestic production.

As part of his latest tariff drive, Trump also imposed duties of 50 percent on kitchen cabinets and bathroom vanities, 30 percent on upholstered furniture, and 25 percent on heavy trucks.

While offe...